Does BELATACEPT Cause Progressive multifocal leukoencephalopathy? 48 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 48 reports of Progressive multifocal leukoencephalopathy have been filed in association with BELATACEPT (NULOJIX). This represents 1.4% of all adverse event reports for BELATACEPT.
48
Reports of Progressive multifocal leukoencephalopathy with BELATACEPT
1.4%
of all BELATACEPT reports
34
Deaths
35
Hospitalizations
How Dangerous Is Progressive multifocal leukoencephalopathy From BELATACEPT?
Of the 48 reports, 34 (70.8%) resulted in death, 35 (72.9%) required hospitalization, and 18 (37.5%) were considered life-threatening.
Is Progressive multifocal leukoencephalopathy Listed in the Official Label?
Yes, Progressive multifocal leukoencephalopathy is listed as a known adverse reaction in the official FDA drug label for BELATACEPT.
What Other Side Effects Does BELATACEPT Cause?
Off label use (304)
Death (206)
Transplant rejection (178)
Cytomegalovirus infection (142)
Drug ineffective (142)
Product storage error (142)
Acute kidney injury (137)
Covid-19 (129)
Hospitalisation (123)
Kidney transplant rejection (97)
What Other Drugs Cause Progressive multifocal leukoencephalopathy?
NATALIZUMAB (1,668)
RITUXIMAB (1,647)
CYCLOPHOSPHAMIDE (782)
PREDNISONE (606)
PREDNISOLONE (439)
TACROLIMUS (438)
METHOTREXATE (428)
DOXORUBICIN (421)
MYCOPHENOLATE MOFETIL (414)
VINCRISTINE (376)
Which BELATACEPT Alternatives Have Lower Progressive multifocal leukoencephalopathy Risk?
BELATACEPT vs BELIMUMAB
BELATACEPT vs BELINOSTAT
BELATACEPT vs BELUMOSUDIL
BELATACEPT vs BELVIQ
BELATACEPT vs BELZUTIFAN